ProfileGDS5822 / ILMN_1234848
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 20% 7% 37% 1% 6% 30% 18% 51% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11320
GSM1276600PDAC Late Ablation Control 210.87
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.337
GSM1276603PDAC Late Ablation 21.41
GSM1276604PDAC Late Ablation 36.56
GSM1303940PDAC Late Ablation_anti-CTLA4 115.630
GSM1303941PDAC Late Ablation_anti-CTLA4 29.918
GSM1303942PDAC Late Ablation_anti-CTLA4 326.851